Subscribe

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Print Download
Ovarian Cancer
How to Sequence Treatment in Relapsed Ovarian Cancer
Read More
Ovarian Cancer
Maintenance Gemogenovatucel-T Immunotherapy in Newly Diagnosed Advanced Ovarian Cancer
Read More
Ovarian Cancer
Patient Self-Reporting of Tolerability in Phase 2 Trial Comparing Gemcitabine plus Adavosertib or Placebo in Women with Platinum-Resistant Epithelial Ovarian Cancer
Read More
Ovarian Cancer
Mirvetuximab Soravtansine plus Bevacizumab in Patients with Recurrent Ovarian Cancer
Read More
Ovarian Cancer
NeoPembrOV Study of Neoadjuvant Chemotherapy with or without Pembrolizumab Followed by Interval Debulking Surgery and Standard Systemic Therapy with or without Pembrolizumab for Advanced High-Grade Serous Carcinoma
Read More
Ovarian Cancer
Optimal Treatment Duration of Bevacizumab plus Carboplatin/Paclitaxel in Advanced Ovarian Cancer
Read More
Ovarian Cancer
Phase 1 Study of GAS6/AXL Inhibitor (AVB-500) in Recurrent, Platinum-Resistant Ovarian Carcinoma
Read More
Ovarian Cancer
Anlotinib in Combination with TQB2450 in Patients with Recurrent Ovarian Cancer (ACTION)
Read More
Ovarian Cancer
Niraparib Efficacy and Safety in Patients with BRCA-Mutated Ovarian Cancer from 3 Phase 3 Trials
Read More
Ovarian Cancer
Real-World Treatment Patterns of Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer
Read More
Page 1 of 3
Results 1 - 10 of 30
© Amplity Health. All rights reserved.